BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 26969382)

  • 21. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway.
    Jiang JH; Pi J; Cai JY
    Pathol Res Pract; 2020 Aug; 216(8):153031. PubMed ID: 32703495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo.
    Kim EC; Kim SH; Piao SJ; Kim TJ; Bae K; Kim HS; Hong SS; Lee BI; Nam M
    J Korean Med Sci; 2015 Jul; 30(7):979-87. PubMed ID: 26130964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
    Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
    Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer and anti-angiogenic activities of extract from Actinidia eriantha Benth root.
    Wu JG; Ma L; Lin SH; Wu YB; Yi J; Yang BJ; Wu JZ; Wong KH
    J Ethnopharmacol; 2017 May; 203():1-10. PubMed ID: 28323051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway.
    Huang B; Peng Y; Li J; Li S; Sun Y; Wang D; Yang B; Chan JY; Yu H; Leung GP; Hoi MP; Zhou GC; Lee SM
    Mol Biosyst; 2017 Feb; 13(3):525-536. PubMed ID: 28098292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling.
    Jin S; Yun HJ; Jeong HY; Oh YN; Park HJ; Yun SG; Kim BW; Kwon HJ
    Oncol Rep; 2015 Sep; 34(3):1178-84. PubMed ID: 26133679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
    Yue GG; Lee JK; Kwok HF; Cheng L; Wong EC; Jiang L; Yu H; Leung HW; Wong YL; Leung PC; Fung KP; Lau CB
    Sci Rep; 2015 Jun; 5():11149. PubMed ID: 26053458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extract of Polygoni Cuspidati Rhizoma et Radix suppresses the vascular endothelial growth factor-induced angiogenesis.
    Hu WH; Chan GK; Lou JS; Wu QY; Wang HY; Duan R; Cheng MY; Dong TT; Tsim KW
    Phytomedicine; 2018 Mar; 42():135-143. PubMed ID: 29655679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
    Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
    BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AGS-30, an andrographolide derivative, suppresses tumor angiogenesis and growth in vitro and in vivo.
    Li J; Li F; Tang F; Zhang J; Li R; Sheng D; Lee SM; Zhou GC; Leung GP
    Biochem Pharmacol; 2020 Jan; 171():113694. PubMed ID: 31706845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
    Shi J; Lu Y; Wei P
    J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Liang N; Li Y; Chung HY
    Int J Oncol; 2017 Jul; 51(1):213-222. PubMed ID: 28534941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2.
    Pan CH; Lin WH; Chien YC; Liu FC; Sheu MJ; Kuo YH; Wu CH
    Toxicol Appl Pharmacol; 2015 Jan; 282(2):215-26. PubMed ID: 25481497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic effect of auranofin on HUVECs in vitro and zebrafish in vivo.
    He MF; Gao XP; Li SC; He ZH; Chen N; Wang YB; She JX
    Eur J Pharmacol; 2014 Oct; 740():240-7. PubMed ID: 25064343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.